You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Kappa

Showing 1 - 25 of 1,770
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Alcohol Use Disorder Trial (Detoxification Program, PKAB, CFN)

Not yet recruiting
  • Alcohol Use Disorder
  • Detoxification Program
  • +2 more
  • (no location specified)
Jul 13, 2023

Angle Kappa , Corneal High Order Aberrations and Total Eye

Not yet recruiting
  • Aberration, Corneal Wavefront
  • Pentacam Imaging
  • (no location specified)
Feb 14, 2023

Opioid Use Disorder Trial (CVL-354, [11C]-LY2795050, [11C]-carfentanil)

Not yet recruiting
  • Opioid Use Disorder
  • New Haven, Connecticut
    New Haven, Connecticut
Jan 18, 2023

Alcohol Drinking Trial in New Haven (Naltrexone)

Completed
Has Results
  • Alcohol Drinking
  • New Haven, Connecticut
    Sac, Cmhc
Aug 8, 2022

CSF Free Kappa Light Chain for The Diagnosis of Demyelinating

Completed
  • Multiple Sclerosis
  • Kappa Free Light Chain (K-FLC)
  • Karachi, Sindh, Pakistan
    Clinical Chemistry, Sopari wala building
Apr 20, 2022

Mantle Cell Lymphoma, Follicular Lymphoma, Splenic Marginal Zone Lymphoma Trial in Chapel Hill (CAR.k.28, Fludarabine,

Recruiting
  • Mantle Cell Lymphoma
  • +5 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Nov 19, 2021

Lymphoma, Myeloma, Leukemia Trial in Houston (Kappa CD28 T cells)

Recruiting
  • Lymphoma
  • +2 more
  • Kappa CD28 T cells
  • Houston, Texas
  • +1 more
Jan 31, 2022

Studies of the Angle Kappa and the Angle Alpha

Completed
  • No Eye Disorder
  • Eye examination
  • Paris, France
    Hôpital Necker-Enfants Malades
Oct 28, 2021

Oxidative Stress, Inflammation Trial in Ede (Vitamin K2, Placebo)

Active, not recruiting
  • Oxidative Stress
  • Inflammation
  • Vitamin K2
  • Placebo
  • Ede, Netherlands
    NIZO food research
Feb 2, 2023

Amblyopia Trial in Columbus (Optical Correction, Therapeutic Dichoptic Virtual Reality Games)

Recruiting
  • Amblyopia
  • Optical Correction
  • Therapeutic Dichoptic Virtual Reality Games
  • Columbus, Ohio
    The Ohio State University College of Optometry
Sep 22, 2023

Type II Diabetes Trial in Corbeil-Essonnes (pratice physical activity)

Recruiting
  • Type II Diabetes
  • pratice physical activity
  • Corbeil-Essonnes, France
    Centre Hospitalier Sud Francilien
May 10, 2022

Periimplant Soft Tissue Phenotype on Marginal Bone Loss

Completed
  • Alveolar Bone Loss
  • +2 more
  • Nuclear Factor-Kappa B Ligand (RANKL) analysis
  • +4 more
  • Konya, Turkey
    Necmettin Erbakan University, dentistry Faculty
Jan 24, 2023

Inflammation, Oxidative Stress, Vitamin K Trial in Glasgow (Vitamin K2, Micro-crystalline cellulose)

Recruiting
  • Inflammation
  • +5 more
  • Vitamin K2
  • Micro-crystalline cellulose
  • Glasgow, United Kingdom
  • +1 more
Nov 1, 2022

Healthy Participant Trial in Paris (Club event)

Completed
  • Healthy Participant
  • Club event
  • Paris, France
    ANRS
Apr 1, 2022

Beclometasone/Formoterol/Glycopyrronium DPI in Chronic

Not yet recruiting
  • COPD
  • Beclometasone/Formoterol/Glycopyrronium 88 µg/5 µg/9 µg DPI (Trimbow® 88 µg/5 µg/9 µg in NEXThaler device)
  • (no location specified)
Jul 10, 2023

Diabete Type 2 Trial in Kuwait City (Placebo, Vitamin K2)

Recruiting
  • Diabete Type 2
  • Placebo
  • Vitamin K2
  • Kuwait City, Kuwait
    Dasman Diabetes Institute
May 11, 2022

Healthy Trial in West Haven (Salvinorin A, Placebo)

Completed
  • Healthy
  • Salvinorin A
  • Placebo
  • West Haven, Connecticut
    VA Connecticut Healthcare System
Apr 6, 2022

PanOptix and Angle Kappa

Active, not recruiting
  • Pseudophakia
  • Angle Kappa
  • Visual disturbance questionnaire.
  • Mount Pleasant, South Carolina
    Carolina Eyecare Physicians, LLC
Mar 2, 2021

s of Kappa and Lambda Free Light Chains in Central Nervous

Completed
  • Central Nervous System Diseases
  • Multiple Sclerosis
  • Biological collection
  • Clermont-Ferrand, France
  • +13 more
Nov 8, 2021

Locally Advanced Basal Cell Carcinoma Trial in Philadelphia (biological, procedure, other)

Not yet recruiting
  • Locally Advanced Basal Cell Carcinoma
  • Cemiplimab
  • +3 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Jun 28, 2023

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta (Tocilizumab, Venetoclax)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jan 24, 2023

Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (biological, drug, other)

Recruiting
  • Biochemically Recurrent Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Durvalumab
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 26, 2023

Chronic Lymphocytic Leukemia, Richter Syndrome, Small Lymphocytic Lymphoma Trial in Rochester (Acalabrutinib, Durvalumab,

Recruiting
  • Chronic Lymphocytic Leukemia
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8 Trial in Rochester (Durvalumab, Radiation Therapy)

Not yet recruiting
  • Lung Non-Small Cell Carcinoma
  • Stage III Lung Cancer AJCC v8
  • Durvalumab
  • Radiation Therapy
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Prognostic Prediction Based on Radiomics of Giant Cell Tumor of

Completed
  • Spinal Tumor
  • RANK/RANKL(RANK: Receptor Activator of Nuclear factor Kappa-Β /RANKL:Receptor Activator of Nuclear factor Kappa-Β Ligand)
  • Beijing, Please Select An Option Below, China
    Peking University third hospital
Jun 28, 2021